Synthesis of novel 2',3'-didehydro-2',3'-dideoxyinosine phosphoramidate prodrugs and evaluation of their anticancer activity

Nucleosides Nucleotides Nucleic Acids. 2014;33(8):507-18. doi: 10.1080/15257770.2014.898070.

Abstract

An efficient synthesis of 4-chlorophenyl N-alkyl phosphoramidates of 2 ',3 '-didehydro-2 ',3 '-dideoxyinosine employing 4-chlorophenyl phosphoroditetrazolide as a phosphorylating agent is reported. Improved method for the synthesis of 2 ',3 '-didehydro-2 ',3 '-dideoxyinosine starting from inosine is also described. The synthesized phosphoramidates 11-18 were examined for their cytotoxic activity in three human cancer cell lines: cervical (HeLa), oral (KB), and breast (MCF-7) employing sulforhodamine B assay. The highest activity in all investigated cancer cell lines was displayed by phosphoramidate 13 with N-n-propyl substituent.

Keywords: 2′,3′-didehydro-2′,3′-dideoxyinosine; Phosphorylation; anticancer activity; phosphoramidate; prodrug.

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Chemistry Techniques, Synthetic
  • Didanosine / chemical synthesis*
  • Didanosine / chemistry
  • Didanosine / pharmacology*
  • Humans
  • Inhibitory Concentration 50
  • Prodrugs / chemical synthesis*
  • Prodrugs / chemistry
  • Prodrugs / pharmacology*

Substances

  • Antineoplastic Agents
  • Prodrugs
  • Didanosine